Company Profile
IXICO provides data analytics services to biopharmaceutical industry globally. The company offers collection, analysis, management, and reporting on gathered clinical study data.
Its portfolio also includes neurological diseases data collection and analysis, and sales and marketing services, as well as imaging contract research organization solutions including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI.
Its portfolio also includes trial management, data analytics, post marketing surveillance and clinical diagnostics, and consultancy services. Additionally, it offers IXICO platform, an AI-enabled technology platform for neuroimaging data management and analysis. Its services are used for various therapeutic areas comprising Alzheimer's, Huntington's, Multiple Sclerosis, and Parkinson's diseases
Other rare neurological diseases, other Demyelinating disorders, and Parkinsonian disorders. It has collaboration with Medidata to create neuroimaging clinical trials platform. The company is based in London, the United Kingdom.